Evgen

1 day ago

Bookmark

Evgen is a company. It is in Nether Alderley, the United Kingdom and its CEO is Huw Jones. It was founded in 2007 and is part of the Health Care sector, specifically in the Biotechnology industry.

Key facts

See more facts

Download datasets about Evgen:

Stocks from Evgen:

TheraCryf | Developing therapeutics in oncology and behavioural brain disorders
TherCryf is a clinical drug development company developing sulforaphane-based medicines focussed on the treatment of cancer and inflammation.
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions
Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Our pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of ...
Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib
IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

Connected or similar to Evgen: .

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.